We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

92 hedge funds and large institutions have $1.13B invested in IVERIC bio, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 25

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

4% less capital invested

Capital invested by funds: $1.18B → $1.13B (-$51.1M)

6% less funds holding

Funds holding: 98 → 92 (-6)

10% less call options, than puts

Call options by funds: $6M | Put options by funds: $6.67M

30% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 20

Holders
92
Holders Change
-6
Holders Change %
-6.12%
% of All Funds
2.67%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.2%
New
14
Increased
33
Reduced
25
Closed
20
Calls
$6M
Puts
$6.67M
Net Calls
-$674K
Net Calls Change
+$2.52M

Top Buyers

1
JCG
JHL Capital Group
Illinois
+$13.3M
2
O
OrbiMed
New York
+$13.3M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$6.9M
4
PA
Perceptive Advisors
New York
+$5.84M
5
State Street
State Street
Massachusetts
+$3.3M

Top Sellers

1
FWIA
Fort Washington Investment Advisors
Ohio
-$5.01M
2
HLA
Hamilton Lane Advisors
Pennsylvania
-$3.91M
3
HCM
Highbridge Capital Management
New York
-$3.47M
4
SOMRS
State of Michigan Retirement System
Michigan
-$3.47M
5
California Public Employees Retirement System
California Public Employees Retirement System
California
-$3.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$268M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$192M – – –
SHI
3
SV Health Investors
Massachusetts
$129M – – –
JCG
4
JHL Capital Group
Illinois
$120M +$13.3M +340,000 +12%
CV
5
Clarus Ventures
Massachusetts
$60.5M – – –
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$53.3M +$6.9M +175,827 +15%
EAM
7
Eagle Asset Management
Florida
$52.7M -$73.8K -1,880 -0.1%
Vanguard Group
8
Vanguard Group
Pennsylvania
$37.2M +$3.03M +77,265 +9%
RCM
9
RA Capital Management
Massachusetts
$22.9M +$2.39M +61,000 +12%
State Street
10
State Street
Massachusetts
$22.9M +$3.3M +84,150 +17%
PA
11
Perceptive Advisors
New York
$20.3M +$5.84M +148,696 +40%
Morgan Stanley
12
Morgan Stanley
New York
$16.5M +$1.42M +36,151 +9%
O
13
OrbiMed
New York
$13.2M +$13.3M +338,800 New
GPP
14
Great Point Partners
Connecticut
$11.7M +$1.96M +49,900 +20%
BFA
15
BlackRock Fund Advisors
California
$11.7M -$257K -6,547 -2%
Goldman Sachs
16
Goldman Sachs
New York
$9.15M -$96.3K -2,453 -1%
Allianz Asset Management
17
Allianz Asset Management
Germany
$8.52M +$480K +12,240 +6%
Northern Trust
18
Northern Trust
Illinois
$5.73M +$909K +23,151 +19%
BIT
19
BlackRock Institutional Trust
California
$5.71M -$483K -12,296 -8%
Barclays
20
Barclays
United Kingdom
$4.73M -$307K -7,828 -6%
MAA
21
Managed Account Advisors
New Jersey
$3.68M +$930K +23,702 +34%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$3.54M +$343K +8,748 +11%
GC
23
Guggenheim Capital
Illinois
$3.26M +$2.15M +54,687 +188%
Axa
24
Axa
France
$3.24M +$3.27M +83,306 New
AP
25
AlpInvest Partners
Netherlands
$3.19M – – –
1
2 3 4 5

ISEE Hedge Fund Activity: Q3 2014 in Review

92 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2014, worth a combined $1.13B — down 4.3% from $1.18B a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ISEE and 14 opened new positions — a net loss of 6 holders — while 25 trimmed existing stakes and 33 added.

The largest buyer was JHL Capital Group, adding an estimated $13.3M. The largest seller was Fort Washington Investment Advisors, cutting an estimated $5.01M.

  • 92 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2014, down from 98 in Q2 2014.
  • Funds reported $1.13B of IVERIC bio, Inc. Common Stock stock for Q3 2014, down 4.3% quarter-over-quarter.
  • 14 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2014 and 20 closed out, a net change of -6 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q3 2014 was JHL Capital Group, an estimated $13.3M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q3 2014 was Fort Washington Investment Advisors, an estimated $5.01M sold.

Based on aggregated 13F filings for Q3 2014.